Living with Advanced Breast Cancer: Challenges and Opportunities
•Download as PPT, PDF•
2 likes•2,626 views
- Metastatic breast cancer poses significant challenges as it is incurable and can recur even after early-stage treatment, with over 500,000 deaths worldwide annually. Living with metastatic disease differs profoundly from early-stage experiences. - Two surveys of over 1,000 metastatic breast cancer patients across countries found high levels of fear, confusion and depression upon diagnosis. While most received family support, many felt stigma and isolation. Information seeking helped patients cope. - More research funding and clinical trials inclusive of quality of life are needed. Counting metastatic cases is important to assess needs and allocate resources for supportive care and treatments that meaningfully extend survival and quality of life for these patients. Guidelines can help patients navigate a still deadly disease.
Report
Share
Report
Share
![The Global Burden of Advanced Breast Cancer ,[object Object],[object Object],[object Object],[object Object],WHO, 2008 O’Shaughnessy, The Oncologist, 2005 WHO. Cancer Fact Sheet, 2011](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
Communities of Color and Participation in Breast Cancer Research
40 percent of Americans belong to a minority racial or ethnic group, yet only 2 percent of cancer clinical trials have studied enough minorities to provide useful information to these populations. In this webinar Dr. Susan Love, from the Dr. Susan Love Research Foundation, presents on the importance of including communities of color in breast cancer research, the barriers to diversifying research, and what can be done to address them.
SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...
Annie Ellis, ovarian cancer survivor and research advocate, presented about research presented at the annual meeting.
Report Back from ASCO on Metastatic Breast Cancer
Dr. Anne Moore, Medical Director of the Weill Cornell Breast Center, shares her experiences from the American Society of Clinical Oncology's June 2017 Conference. She also updates us on the latest research from the conference as it relates to metastatic breast cancer.
Invasive Lobular Carcinoma — Highlights from the First Ever ILC Symposium
Steffi Osterreich, PhD, and Rachel Jankowitz, MD, of University of Pittsburgh Cancer Institute, join Heather Hillier, breast advocate and co-chair of the first international ILC Symposium, in offering an overview of Invasive Lobular Carcinoma and highlights from the conference, which took place in Pittsburgh in September 2016. The program was presented in collaboration with MBCN.
Immunotherapy Update for Ovarian Cancer
Dr. Maurie Markman, President of Science and Medicine at Cancer Treatment Centers of America, shares his expertise on the latest developments in immunotherapy for ovarian cancer.
Uterine and Endometrial Cancer 101
Uterine and endometrial cancer are the most common gynecologic cancers. Risk factors include obesity, tamoxifen use, and certain genetic conditions. Diagnosis involves endometrial biopsy. Treatment typically involves hysterectomy with or without radiation or chemotherapy depending on risk factors like tumor grade and stage. New immunotherapies are showing promise for recurrent or advanced disease. Precision medicine approaches are helping to classify subtypes and identify targeted therapies.
SHARE Presentation: New Developments in the Medical Treatment of Breast Cance...
Dr. Cliff Hudis on the latest information on new breast cancer treatments. Dr. Hudis is Chief of Breast Cancer Medicine Service at Memorial Sloan-Kettering Cancer Center.
Aggressive Breast Cancers in Black Women
Black women experience higher rates of breast cancer and mortality compared to other groups in the US. Some factors that may contribute include less access to screening and treatment, as well as a higher frequency of more aggressive tumor subtypes like triple negative breast cancer. Research has found Black women are also more likely to be diagnosed with breast cancers that have exhausted immune cells surrounding the tumor. Factors like ancestry, a stronger pro-inflammatory response, lower breastfeeding rates, and lower vitamin D levels may all play a role in the increased aggressiveness seen in Black women's breast cancers. Ongoing research aims to better understand and address these disparities.
Recommended
Communities of Color and Participation in Breast Cancer Research
40 percent of Americans belong to a minority racial or ethnic group, yet only 2 percent of cancer clinical trials have studied enough minorities to provide useful information to these populations. In this webinar Dr. Susan Love, from the Dr. Susan Love Research Foundation, presents on the importance of including communities of color in breast cancer research, the barriers to diversifying research, and what can be done to address them.
SHARE: Report Back from Annual Meeting of American Association of Cancer Rese...
Annie Ellis, ovarian cancer survivor and research advocate, presented about research presented at the annual meeting.
Report Back from ASCO on Metastatic Breast Cancer
Dr. Anne Moore, Medical Director of the Weill Cornell Breast Center, shares her experiences from the American Society of Clinical Oncology's June 2017 Conference. She also updates us on the latest research from the conference as it relates to metastatic breast cancer.
Invasive Lobular Carcinoma — Highlights from the First Ever ILC Symposium
Steffi Osterreich, PhD, and Rachel Jankowitz, MD, of University of Pittsburgh Cancer Institute, join Heather Hillier, breast advocate and co-chair of the first international ILC Symposium, in offering an overview of Invasive Lobular Carcinoma and highlights from the conference, which took place in Pittsburgh in September 2016. The program was presented in collaboration with MBCN.
Immunotherapy Update for Ovarian Cancer
Dr. Maurie Markman, President of Science and Medicine at Cancer Treatment Centers of America, shares his expertise on the latest developments in immunotherapy for ovarian cancer.
Uterine and Endometrial Cancer 101
Uterine and endometrial cancer are the most common gynecologic cancers. Risk factors include obesity, tamoxifen use, and certain genetic conditions. Diagnosis involves endometrial biopsy. Treatment typically involves hysterectomy with or without radiation or chemotherapy depending on risk factors like tumor grade and stage. New immunotherapies are showing promise for recurrent or advanced disease. Precision medicine approaches are helping to classify subtypes and identify targeted therapies.
SHARE Presentation: New Developments in the Medical Treatment of Breast Cance...
Dr. Cliff Hudis on the latest information on new breast cancer treatments. Dr. Hudis is Chief of Breast Cancer Medicine Service at Memorial Sloan-Kettering Cancer Center.
Aggressive Breast Cancers in Black Women
Black women experience higher rates of breast cancer and mortality compared to other groups in the US. Some factors that may contribute include less access to screening and treatment, as well as a higher frequency of more aggressive tumor subtypes like triple negative breast cancer. Research has found Black women are also more likely to be diagnosed with breast cancers that have exhausted immune cells surrounding the tumor. Factors like ancestry, a stronger pro-inflammatory response, lower breastfeeding rates, and lower vitamin D levels may all play a role in the increased aggressiveness seen in Black women's breast cancers. Ongoing research aims to better understand and address these disparities.
Report Back from SGO: What’s the Latest in Uterine Cancer?
Dr. Jeannine Villella, Chief of Gynecologic Oncology at Lenox Hill Hospital, provides a comprehensive update from the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer. Dr. Villella breaks down what the research presented at the conference means for you and discusses new developments.
Navigating Nutrition During Cancer and COVID-19
Nutrition can be puzzling enough, but when you add a cancer diagnosis and a global pandemic, it’s even harder to make sense of it all. Julie Lanford, MPH, RD, CSO, LDN, "The Cancer Dietitian" for Cancer Services, will help put the pieces together so you’re equipped to navigate nutrition during cancer and COVID-19.
All in the Family: Hereditary Risk for Gynecologic Cancer
Knowing and understanding your inherited genetics is important for ovarian and uterine cancer patients. Dr. Melissa Frey, gynecologic oncologist at Weill Cornell Medicine, discusses how genetic factors affect women with ovarian and uterine cancer and influence treatment decisions, with a particular focus on BRCA1 & 2 and Lynch Syndrome.
This webinar was being put on in partnership with FORCE.
Uterine Cancer Recurrence: All You Need To Know
t's not uncommon for uterine cancer survivors to worry about recurrence.
Whether you've had a recurrence or want to become more informed, join Dr. Susan C. Modesitt, Director of Gynecologic Oncology at UVA Cancer Center, to learn more information about uterine cancer recurrence as well as available treatment options.
Ovarian Cancer: What's New?
Dr. Stephanie Blank and Dr. Melissa Frey update us on the latest developments in ovarian cancer research and treatment from the annual conference of the Society of Gynecologic Oncology. Dr. Blank is a gynecologic oncologist at Perlmutter Cancer Center at NYU Langone Medical Center and an associate professor at NYU School of Medicine. Dr. Frey is a Gynecological Oncology Fellow at NYU Langone Medical Center.
Topic-Driven Round Table on Ovarian Cancer: Understanding Genetics and Ovaria...
Women with ovarian cancer joined Julie Larson, LCSW, guest speaker Dr. Kathryn Pennington of UW Medicine, and peers via video or phone to discuss genetics and ovarian cancer.
Older Adult Survivorship
This document discusses older adult survivorship issues. Key points include: the aging population is growing and older adults account for over half of cancer cases; physiological changes in aging can impact cancer treatment and outcomes; comprehensive geriatric assessments should be conducted prior to treatment; guidelines recommend adjusting treatment based on goals and function rather than age alone; and common geriatric syndromes like falls, polypharmacy, and pain management need special consideration in older cancer survivors.
DCIS Topic-Driven Round Table: Decision-Making and Treatment Choices
Facilitator Deb Hackenberry is joined by Cecilia Hammond, Senior Medical Science Liaison at Genomic Health, to discuss better decision-making and your treatment choices with DCIS.
Clinical Trials for Ovarian Cancer: Fact vs. Fiction
Courtney Hudson, CEO & Co-Founder of EmergingMed, explains the basics of clinical trials and the process of developing new treatments in the emerging age of personalized medicine and immunotherapy. Lean how to identify appropriate clinical trials, find strategies to determine your best options, and figure out which questions to ask when making your decisions. Watch the accompanying webinar: https://vimeo.com/203510985
Advancing The Prevention And Cure Of Cancer
The document discusses the shared missions and collaborations between the American Association for Cancer Research (AACR) and the National Cancer Institute (NCI) to advance cancer research and reduce the burden of cancer. It outlines their joint efforts in conferences, workshops, and think tanks. It also summarizes advances in cancer prevention, early detection, and treatment that have contributed to reduced cancer mortality rates in recent years but challenges remain.
New and improved breast cancer
Breast cancer is a tumor that starts in the cells of the breast, usually developing in the milk producing glands. Some potential causes of breast cancer include being female, increasing age, family history, and lifestyle factors like smoking. Breast cancer can be treated through surgery to remove the tumor, radiation therapy to destroy remaining cancer cells, and chemotherapy which uses medication to destroy cancer cells throughout the body. While breast cancer cannot always be prevented, early detection through screening and treatment can help reduce the risk of the disease spreading.
Strategies for Long-term Management of Recurrent Ovarian Cancer
A panel of doctors and patients will discuss decision-making in the recurrent setting of ovarian cancer, including how to understand and consider options like chemotherapy, surgery, and clinical trials. Panelists include Dr. Jason Wright and Dr. June Hou from Columbia University College of Physicians and Surgeons, survivor/research advocate Annie Ellis, and others living with recurrence.
Survivorship Care Plans
The document discusses survivorship care plans (SCPs), which are recommended by the Institute of Medicine to provide cancer patients completing primary treatment with a comprehensive care summary and follow-up plan. SCPs aim to prevent and detect new cancers, coordinate care, and address late or long-term effects of cancer treatment. Several organizations have developed SCP templates, and the Commission on Cancer requires SCPs to be implemented by 2015. However, literature reviews show limited evidence that SCPs improve patient outcomes. Barriers to implementing SCPs include the length of time needed to create them and lack of resources. Providers, patients, and oncologists agree SCPs are important in summarizing cancer care, but more
Addressing your COVID-19 Breast Cancer Concerns
Dr. Anne Moore, medical oncologist and Director of the Breast Cancer Survivorship Program at Weill Cornell and Dr. Leticia Varella, Assistant Professor of Medicine at Weill Cornell Medical College will go over changes in treatment and maintenance care for those with an early stage or metastatic breast cancer diagnosis. They will address your risk level as a cancer patient, provide strategies to minimize risk, discuss how to deal with anxiety, and answer your questions to help you through the COVID-19 pandemic.
Communicating hope and truth: A presentation for health care professionals
This document discusses improving cancer communication between doctors and patients. It begins with some cancer epidemiology statistics in the US. The main points are:
- The language used in oncology, such as "war on cancer", can imply meanings that increase patient anxiety and imply blame.
- Terms like "early detection" and "screening saves lives" may give patients a false sense of prevention or cure.
- Doctors should acknowledge patient emotions, use plain language, present information in bite-sized chunks, and encourage participation in decision making.
- When discussing risks, benefits, and the future, doctors should address patient concerns directly and not minimize their experiences. The goal is to provide trust and hope while still being honest.
Myth About Cancer By Rcdohare
The document discusses 10 common myths about cancer, including that all cancers are the same, that cell phones cause cancer, and that a positive attitude alone can cure cancer. It explains that while there is no single cure for cancer as a broad category, individual cancers can be cured through various treatments. It also debunks myths that artificial sweeteners and cancer screenings always find cancerous lumps. The document aims to provide accurate information about cancer and dispel widely believed misconceptions.
Finding a Clinical Trial That's Right for You
Elly Cohen, PhD, Program Director of BreastCancerTrials.org, works closely with breast cancer organizations that promote patient awareness of clinical trials as a routine option for care. In this webinar, Elly walked listeners through the steps involved in finding clinical trials that are specific to their diagnosis.
Intermittent Fasting: How it Can Reduce the Risk of Breast Cancer Recurrence
Breast cancer recurrence is the greatest fear for those with breast cancer. While many survivors know that being overweight can contribute to recurrence of their cancer, the thought of dieting and how to go about it can be overwhelming. Dr. Nicholas Webster, Professor of Medicine, Chief of the Division of Endocrinology and Metabolism, and Associate Director for Shared Resources, Moores Cancer Center discusses his study that suggests a path that is easy to follow and produces the type of results that can be a matter of life and death for some breast cancer patients.
DCIS: What You Need to Know
A diagnosis of DCIS often brings mixed messages. Is this a real breast cancer? What is the meaning of Stage 0? If this is not life threatening, why are the treatments similar to those recommended for an invasive cancer? Deborah Collyar, founder of Patient Advocates in Research, helps us interpret the new findings that will aid you in navigating this diagnosis.
Breast ca risk
This document summarizes several breast cancer risk assessment models. It discusses two main types of risk assessment: the chances of developing breast cancer over time, and the chances of carrying a mutation in a high-risk gene like BRCA1/2. Several models are described that assess these risks, including the Gail model, Claus model, BRCAPRO, and Cuzick-Tyrer models. Each model incorporates different sets of risk factors and has varying levels of validation and ability to predict cancer risk. The document advocates that improved models integrating more genetic and lifestyle risk factors could achieve more accurate individualized risk prediction.
ABC1 - P. Ganz - Relevant endpoints for advanced breast cancer patients
This document discusses relevant endpoints for clinical trials involving patients with advanced breast cancer. It notes that these patients are a heterogeneous population with different disease characteristics and needs. While traditional endpoints like progression-free survival are important, patient-reported outcomes that measure symptom control, physical functioning, and quality of life are also critical given the focus on long-term management of the disease. The document recommends that phase III trials incorporate patient-reported outcomes to better assess new treatments' impact on symptoms and functioning from the patient perspective.
Breast Cancer and Its Health, Economic, and Social Consequences on Health Car...
Breast Cancer and Its Health, Economic, and Social Consequences on Health Car...Conferenceproceedings
4th International Conference on Emerging Trends in
Scientific Research
28-29 November, 2015
Nippon Hotel, İstanbul-TurkeyMore Related Content
What's hot
Report Back from SGO: What’s the Latest in Uterine Cancer?
Dr. Jeannine Villella, Chief of Gynecologic Oncology at Lenox Hill Hospital, provides a comprehensive update from the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer. Dr. Villella breaks down what the research presented at the conference means for you and discusses new developments.
Navigating Nutrition During Cancer and COVID-19
Nutrition can be puzzling enough, but when you add a cancer diagnosis and a global pandemic, it’s even harder to make sense of it all. Julie Lanford, MPH, RD, CSO, LDN, "The Cancer Dietitian" for Cancer Services, will help put the pieces together so you’re equipped to navigate nutrition during cancer and COVID-19.
All in the Family: Hereditary Risk for Gynecologic Cancer
Knowing and understanding your inherited genetics is important for ovarian and uterine cancer patients. Dr. Melissa Frey, gynecologic oncologist at Weill Cornell Medicine, discusses how genetic factors affect women with ovarian and uterine cancer and influence treatment decisions, with a particular focus on BRCA1 & 2 and Lynch Syndrome.
This webinar was being put on in partnership with FORCE.
Uterine Cancer Recurrence: All You Need To Know
t's not uncommon for uterine cancer survivors to worry about recurrence.
Whether you've had a recurrence or want to become more informed, join Dr. Susan C. Modesitt, Director of Gynecologic Oncology at UVA Cancer Center, to learn more information about uterine cancer recurrence as well as available treatment options.
Ovarian Cancer: What's New?
Dr. Stephanie Blank and Dr. Melissa Frey update us on the latest developments in ovarian cancer research and treatment from the annual conference of the Society of Gynecologic Oncology. Dr. Blank is a gynecologic oncologist at Perlmutter Cancer Center at NYU Langone Medical Center and an associate professor at NYU School of Medicine. Dr. Frey is a Gynecological Oncology Fellow at NYU Langone Medical Center.
Topic-Driven Round Table on Ovarian Cancer: Understanding Genetics and Ovaria...
Women with ovarian cancer joined Julie Larson, LCSW, guest speaker Dr. Kathryn Pennington of UW Medicine, and peers via video or phone to discuss genetics and ovarian cancer.
Older Adult Survivorship
This document discusses older adult survivorship issues. Key points include: the aging population is growing and older adults account for over half of cancer cases; physiological changes in aging can impact cancer treatment and outcomes; comprehensive geriatric assessments should be conducted prior to treatment; guidelines recommend adjusting treatment based on goals and function rather than age alone; and common geriatric syndromes like falls, polypharmacy, and pain management need special consideration in older cancer survivors.
DCIS Topic-Driven Round Table: Decision-Making and Treatment Choices
Facilitator Deb Hackenberry is joined by Cecilia Hammond, Senior Medical Science Liaison at Genomic Health, to discuss better decision-making and your treatment choices with DCIS.
Clinical Trials for Ovarian Cancer: Fact vs. Fiction
Courtney Hudson, CEO & Co-Founder of EmergingMed, explains the basics of clinical trials and the process of developing new treatments in the emerging age of personalized medicine and immunotherapy. Lean how to identify appropriate clinical trials, find strategies to determine your best options, and figure out which questions to ask when making your decisions. Watch the accompanying webinar: https://vimeo.com/203510985
Advancing The Prevention And Cure Of Cancer
The document discusses the shared missions and collaborations between the American Association for Cancer Research (AACR) and the National Cancer Institute (NCI) to advance cancer research and reduce the burden of cancer. It outlines their joint efforts in conferences, workshops, and think tanks. It also summarizes advances in cancer prevention, early detection, and treatment that have contributed to reduced cancer mortality rates in recent years but challenges remain.
New and improved breast cancer
Breast cancer is a tumor that starts in the cells of the breast, usually developing in the milk producing glands. Some potential causes of breast cancer include being female, increasing age, family history, and lifestyle factors like smoking. Breast cancer can be treated through surgery to remove the tumor, radiation therapy to destroy remaining cancer cells, and chemotherapy which uses medication to destroy cancer cells throughout the body. While breast cancer cannot always be prevented, early detection through screening and treatment can help reduce the risk of the disease spreading.
Strategies for Long-term Management of Recurrent Ovarian Cancer
A panel of doctors and patients will discuss decision-making in the recurrent setting of ovarian cancer, including how to understand and consider options like chemotherapy, surgery, and clinical trials. Panelists include Dr. Jason Wright and Dr. June Hou from Columbia University College of Physicians and Surgeons, survivor/research advocate Annie Ellis, and others living with recurrence.
Survivorship Care Plans
The document discusses survivorship care plans (SCPs), which are recommended by the Institute of Medicine to provide cancer patients completing primary treatment with a comprehensive care summary and follow-up plan. SCPs aim to prevent and detect new cancers, coordinate care, and address late or long-term effects of cancer treatment. Several organizations have developed SCP templates, and the Commission on Cancer requires SCPs to be implemented by 2015. However, literature reviews show limited evidence that SCPs improve patient outcomes. Barriers to implementing SCPs include the length of time needed to create them and lack of resources. Providers, patients, and oncologists agree SCPs are important in summarizing cancer care, but more
Addressing your COVID-19 Breast Cancer Concerns
Dr. Anne Moore, medical oncologist and Director of the Breast Cancer Survivorship Program at Weill Cornell and Dr. Leticia Varella, Assistant Professor of Medicine at Weill Cornell Medical College will go over changes in treatment and maintenance care for those with an early stage or metastatic breast cancer diagnosis. They will address your risk level as a cancer patient, provide strategies to minimize risk, discuss how to deal with anxiety, and answer your questions to help you through the COVID-19 pandemic.
Communicating hope and truth: A presentation for health care professionals
This document discusses improving cancer communication between doctors and patients. It begins with some cancer epidemiology statistics in the US. The main points are:
- The language used in oncology, such as "war on cancer", can imply meanings that increase patient anxiety and imply blame.
- Terms like "early detection" and "screening saves lives" may give patients a false sense of prevention or cure.
- Doctors should acknowledge patient emotions, use plain language, present information in bite-sized chunks, and encourage participation in decision making.
- When discussing risks, benefits, and the future, doctors should address patient concerns directly and not minimize their experiences. The goal is to provide trust and hope while still being honest.
Myth About Cancer By Rcdohare
The document discusses 10 common myths about cancer, including that all cancers are the same, that cell phones cause cancer, and that a positive attitude alone can cure cancer. It explains that while there is no single cure for cancer as a broad category, individual cancers can be cured through various treatments. It also debunks myths that artificial sweeteners and cancer screenings always find cancerous lumps. The document aims to provide accurate information about cancer and dispel widely believed misconceptions.
Finding a Clinical Trial That's Right for You
Elly Cohen, PhD, Program Director of BreastCancerTrials.org, works closely with breast cancer organizations that promote patient awareness of clinical trials as a routine option for care. In this webinar, Elly walked listeners through the steps involved in finding clinical trials that are specific to their diagnosis.
Intermittent Fasting: How it Can Reduce the Risk of Breast Cancer Recurrence
Breast cancer recurrence is the greatest fear for those with breast cancer. While many survivors know that being overweight can contribute to recurrence of their cancer, the thought of dieting and how to go about it can be overwhelming. Dr. Nicholas Webster, Professor of Medicine, Chief of the Division of Endocrinology and Metabolism, and Associate Director for Shared Resources, Moores Cancer Center discusses his study that suggests a path that is easy to follow and produces the type of results that can be a matter of life and death for some breast cancer patients.
DCIS: What You Need to Know
A diagnosis of DCIS often brings mixed messages. Is this a real breast cancer? What is the meaning of Stage 0? If this is not life threatening, why are the treatments similar to those recommended for an invasive cancer? Deborah Collyar, founder of Patient Advocates in Research, helps us interpret the new findings that will aid you in navigating this diagnosis.
Breast ca risk
This document summarizes several breast cancer risk assessment models. It discusses two main types of risk assessment: the chances of developing breast cancer over time, and the chances of carrying a mutation in a high-risk gene like BRCA1/2. Several models are described that assess these risks, including the Gail model, Claus model, BRCAPRO, and Cuzick-Tyrer models. Each model incorporates different sets of risk factors and has varying levels of validation and ability to predict cancer risk. The document advocates that improved models integrating more genetic and lifestyle risk factors could achieve more accurate individualized risk prediction.
What's hot (20)
Report Back from SGO: What’s the Latest in Uterine Cancer?
Report Back from SGO: What’s the Latest in Uterine Cancer?
All in the Family: Hereditary Risk for Gynecologic Cancer
All in the Family: Hereditary Risk for Gynecologic Cancer
Topic-Driven Round Table on Ovarian Cancer: Understanding Genetics and Ovaria...
Topic-Driven Round Table on Ovarian Cancer: Understanding Genetics and Ovaria...
DCIS Topic-Driven Round Table: Decision-Making and Treatment Choices
DCIS Topic-Driven Round Table: Decision-Making and Treatment Choices
Clinical Trials for Ovarian Cancer: Fact vs. Fiction
Clinical Trials for Ovarian Cancer: Fact vs. Fiction
Strategies for Long-term Management of Recurrent Ovarian Cancer
Strategies for Long-term Management of Recurrent Ovarian Cancer
Communicating hope and truth: A presentation for health care professionals
Communicating hope and truth: A presentation for health care professionals
Intermittent Fasting: How it Can Reduce the Risk of Breast Cancer Recurrence
Intermittent Fasting: How it Can Reduce the Risk of Breast Cancer Recurrence
Viewers also liked
ABC1 - P. Ganz - Relevant endpoints for advanced breast cancer patients
This document discusses relevant endpoints for clinical trials involving patients with advanced breast cancer. It notes that these patients are a heterogeneous population with different disease characteristics and needs. While traditional endpoints like progression-free survival are important, patient-reported outcomes that measure symptom control, physical functioning, and quality of life are also critical given the focus on long-term management of the disease. The document recommends that phase III trials incorporate patient-reported outcomes to better assess new treatments' impact on symptoms and functioning from the patient perspective.
Breast Cancer and Its Health, Economic, and Social Consequences on Health Car...
Breast Cancer and Its Health, Economic, and Social Consequences on Health Car...Conferenceproceedings
4th International Conference on Emerging Trends in
Scientific Research
28-29 November, 2015
Nippon Hotel, İstanbul-Turkey2013 Cancer Survivorship Conference at Jefferson University Hospitals
Jefferson's Cancer Survivorship Program will help you understand what it means to be a cancer survivor and what to expect from your cancer diagnosis, treatment and follow-up care. This Program is for current patients, cancer survivors and loved ones who have lived with a cancer diagnosis or have undergone cancer treatment at Jefferson.
Integrative Oncology
This document discusses integrative oncology and comprehensive care for cancer patients. It defines integrative medicine as combining biomedical care with complementary therapies to heal the whole person - body, mind and spirit. The document notes high rates of complementary and alternative medicine use among cancer patients and barriers to discussing these therapies with oncologists. It emphasizes treating the individual patient and their disease, and the importance of lifestyle factors like diet, exercise and weight in cancer prevention and survival.
Breast cancer ppt
Breast cancer is the second leading cause of death and second most common cancer in women. It occurs when abnormal cells in the breast grow in an uncontrolled way and form tumors. The breasts contain lobes and lobules which produce milk, connected by ducts. The two main types are ductal carcinoma, originating in the ducts, and lobular carcinoma, originating in the lobules. Risk factors include gender, age, family history, obesity, lack of exercise, alcohol consumption, and hormone therapy. Screening methods include breast self-exams, clinical exams by a doctor, and mammography. Treatment options depend on cancer stage and may involve surgery, radiation, chemotherapy, and hormone therapy. With early detection and treatment, the
8 Tips for an Awesome Powerpoint Presentation
The document provides examples of standard, boring presentation templates and encourages the creation of unique, visually appealing templates instead. It emphasizes using fewer words and more images per slide, varying fonts and colors, and breaking content into multiple slides to keep audiences engaged. Inspiration sources like design blogs and galleries of infographics and slide designs are recommended for making impactful presentations that attract and impress audiences.
Viewers also liked (6)
ABC1 - P. Ganz - Relevant endpoints for advanced breast cancer patients
ABC1 - P. Ganz - Relevant endpoints for advanced breast cancer patients
Breast Cancer and Its Health, Economic, and Social Consequences on Health Car...
Breast Cancer and Its Health, Economic, and Social Consequences on Health Car...
2013 Cancer Survivorship Conference at Jefferson University Hospitals
2013 Cancer Survivorship Conference at Jefferson University Hospitals
Similar to Living with Advanced Breast Cancer: Challenges and Opportunities
ABC1 - M. Mayer - Keynote lecture: Living with the Advanced Breast Cancer: Ch...
ABC1 - M. Mayer - Keynote lecture: Living with the Advanced Breast Cancer: Ch...European School of Oncology
The document discusses the challenges of living with advanced or metastatic breast cancer. It notes that over half a million deaths worldwide are caused by advanced breast cancer each year. It also discusses the lack of support and advocacy for those living with metastatic breast cancer compared to those with early-stage disease. Two surveys of patients with advanced breast cancer found that they experience high levels of fear, depression, and anxiety but also demonstrate resilience in coping with their disease. There remains a need for more research, clinical trials, and resources focused specifically on metastatic breast cancer.Why screeing cancer patients for distress will increase disparities in psycho...
Keynote address
Implementing screening of cancer patients for distress will not improve patient outcomes and may aggravate existing biases in who get psychosocial services.
02 foubert
1) An ageing global population is presenting new challenges for cancer care as cancer rates increase with age and older patients have complex needs.
2) Older cancer patients often experience delays in diagnosis and treatment due to ageist attitudes and a lack of clinical research in geriatric oncology. They also have higher rates of co-morbidities.
3) Effective education of nurses is needed to address the diverse needs of older cancer patients, including providing the right amount of individualized information and support to make treatment decisions.
Adolescents and Young Adults With Cancer Treatment and Transition to An Adult...
Adolescents and Young Adults With Cancer Treatment and Transition to An Adult...Methodist HealthcareSA
The document discusses adolescents and young adults with cancer, focusing on their treatment and transition to adult oncology care. It notes that this age group has among the highest cancer incidence rates, poorest health outcomes, and faces unique psychosocial challenges. Specifically, it finds that they have lower rates of health insurance, experience more delayed diagnoses, receive suboptimal treatment dosing, and have worse survival rates than pediatric or older adult cancer patients. The document also examines barriers to appropriate care during the transition period and possible solutions such as establishing healthcare transition teams and increasing education for adult providers.Age Bias in Cancer Care
Studies have shown that older women receive less aggressive screening and treatment for breast cancer. Geriatric Oncologist, Meghan Karuturi, of MD Anderson Cancer Center joins us in this webinar to discuss age bias and how it affects older patients.
Full Public Health Program Proposal: Paper
CAMPSO aims to increase breast cancer patients' and providers' knowledge and use of complementary and alternative medicine (CAM) treatments in Oregon. The program provides CAM education sessions for breast cancer providers led by CAM experts. It also establishes a partnership committee for ongoing CAM discussions between CAM and breast cancer clinicians. Additionally, CAMPSO gives patients brochures on CAM treatments to discuss with their providers. The goal is for CAM to be routinely discussed during treatment to improve patients' health outcomes and quality of life.
Closing the cancer divide for women: An opportunity of lifetimes Women´s Canc...
Closing the cancer divide for women: An opportunity of lifetimes Women´s Canc...Fundación Mexicana para la Salud A.C.
This document discusses strategies for expanding access to cancer care and control in low- and middle-income countries. It proposes a "diagonal approach" that harnesses synergies between disease-specific and health system strengthening programs. Examples of diagonal strategies include integrating cancer screening and treatment into existing maternal and child health programs. The document argues that closing the cancer divide is an equity imperative and that innovative delivery models, affordable drugs and technologies, and evidence-based decision making can help expand access to cancer care in LMICs.Bridging Clinical Gaps and Disparities in Care in TNBC
This webinar will focuses on racial, ethnic, and socioeconomic disparities with the clinical gaps in treatment for women with triple-negative breast cancer (TNBC). Our guest speaker Shonta Chambers, MSW, is the EVP of Health Equity and Community Engagement at the Patient Advocate Foundation and Principal Investigator for SelfMade Health Network. Come and learn about this complex subtype, barriers to care, address the myths and fears around clinical trials in specific racial and ethnic communities, and help bridge the clinical gaps to improve survival outcomes for patients with TNBC.
ICEC_FINAL
This document discusses an interdisciplinary approach to increasing minority participation in cancer clinical trials based on Coale's three preconditions of fertility decline transition theory. The three preconditions are: 1) participation must enter conscious choice, 2) participation must be perceived as advantageous, and 3) effective support for participation must be available. Barriers like cancer fatalism, mistrust in the medical system, socioeconomic factors, and lack of culturally competent resources prevent the preconditions from being met for minorities. The document recommends improving cultural competency, communication, education, staff diversity, and access to address these barriers.
Williams_2015_Lived Expereince of BC Survivors
The document summarizes a qualitative study that explored the lived experiences of 15 breast cancer survivors from diagnosis through treatment and beyond. Three major themes emerged from interviews: 1) coping with the stressful diagnosis and treatment process and adjustments required, with some developing journaling techniques; 2) family support being key to providing strength through treatment; 3) feeling abandoned after treatment ended and uncertainty around what survivorship means. The study provided insight into the experiences of women diagnosed with breast cancer who have completed treatment.
Health Disparities VA Diabetes 2016
This document summarizes research on improving diabetes care for veterans through better digital communication and addressing health literacy issues. It discusses the growing problem of diabetes, especially among veterans and those with low health literacy. Studies at a VA medical center found poor control of diabetes measures like HbA1c and high dropout rates from education programs. The document proposes using surveys to assess individual patients' and clinicians' attitudes and tailoring communication based on clustering analyses. The goal is to improve doctor-patient communication through content tailored to health literacy levels and attitudinal types.
Risk Communication and Medical Decision Making
1. Collective statistical illiteracy in healthcare is widespread among physicians, patients, and politicians due to non-transparent framing of information and lack of risk communication training.
2. Studies show physicians and the public poorly understand concepts like survival rates, risk reductions, and probabilities related to cancer screenings.
3. Implementing transparent risk communication frameworks in medical education and public health materials is needed to improve informed decision making.
Support for Caregivers of Cancer Patient.docx
Support for Caregivers of Cancer Patients: Transition After Active
Treatment
Barbara A. Given, Paula Sherwood and Charles W. Given
Cancer Epidemiol Biomarkers Prev 2011;20:2015-2021.
Updated version Access the most recent version of this article at:
http://cebp.aacrjournals.org/content/20/10/2015
Cited Articles This article cites by 44 articles, 5 of which you can access for free at:
http://cebp.aacrjournals.org/content/20/10/2015.full.html#ref-list-1
E-mail alerts Sign up to receive free email-alerts related to this article or journal.
Reprints and To order reprints of this article or to subscribe to the journal, contact the AACR Publications Department at
Subscriptions [email protected]
Permissions To request permission to re-use all or part of this article, contact the AACR Publications Department at
[email protected]
on September 30, 2013. © 2011 American Association for Cancer Research.cebp.aacrjournals.orgDownloaded from on September 30, 2013. © 2011 American Association for Cancer Research.cebp.aacrjournals.orgDownloaded from on September 30, 2013. © 2011 American Association for Cancer Research.cebp.aacrjournals.orgDownloaded from on September 30, 2013. © 2011 American Association for Cancer Research.Downloaded fromDownloaded fromDownloaded fromDownloaded fromDownloaded from cebp.aacrjournals.org on September 30, 2013. © 2011 American Association for Cancer Research.cebp.aacrjournals.org on September 30, 2013. © 2011 American Association for Cancer Research.cebp.aacrjournals.org on September 30, 2013. © 2011 American Association for Cancer Research.cebp.aacrjournals.org on September 30, 2013. © 2011 American Association for Cancer Research.cebp.aacrjournals.org
http://cebp.aacrjournals.org/content/20/10/2015
http://cebp.aacrjournals.org/content/20/10/2015.full.html#ref-list-1
http://cebp.aacrjournals.org/cgi/alerts
mailto:[email protected]
mailto:[email protected]
http://cebp.aacrjournals.org/
http://cebp.aacrjournals.org/
http://cebp.aacrjournals.org/
http://cebp.aacrjournals.org/
http://cebp.aacrjournals.org/
http://cebp.aacrjournals.org/
http://cebp.aacrjournals.org/
http://cebp.aacrjournals.org/
CEBP FOCUS
Support for Caregivers of Cancer Patients: Transition After
Active Treatment
Barbara A. Given1, Paula Sherwood3, and Charles W. Given2
Abstract
Family caregivers provide uncompensated care and assistance to a family member who has cancer. When
patients move through the care trajectory into the survivorship phase, roles and demands of caregivers change
and caregivers assume responsibility to assist with coordination of ongoing care. The goal of this article is to
describe aspects of caregiver experiences and the roles of caregivers as patients transition from active cancer
treatment into the first and early phase of cancer care. Residual problems for patients and caregivers remain for
some period of time. Cancer Epidemiol Biomarkers Prev; 20(10); 2015–21. �2011 AACR.
Introduction
Family .
Developing a cancer survivorship research agenda - Prof Patricia Ganz
The document summarizes challenges and opportunities for developing a cancer survivorship research agenda. It notes that the aging population will lead to a large increase in cancer cases and survivors in coming decades. Cancer survivors often face significant physical and mental health issues. More research is needed to understand late effects of treatments and better deliver palliative care, prevention, and health promotion to survivors. Opportunities exist to form interdisciplinary teams, study symptoms and comorbidities, develop safer therapies, and test new models of survivor care. Where to start depends on available populations and expertise. Translational research integrating population health and scientific discovery is key.
What's New in Research for ER+ Metastatic Breast Cancer
Nikhil Wagle, MD, discusses new research and how it is leading the way toward improved treatments for ER+ metastatic breast cancer.
Wagle is a physician with the Breast Oncology Program in the Susan F. Smith Center for Women's Cancers at Dana-Farber. He is also a researcher affiliated with Dana-Farber and the Broad Institute.
This presentation was originally given as part of the Metastatic Breast Cancer Forum, held on Oct. 17, 2015 at Dana-Farber Cancer Institute in Boston, Mass.
Setting Up for Survivorship Success
This document summarizes key points from a presentation on establishing survivorship programs. It discusses the need for navigation and survivorship care due to issues cancer survivors face. New CoC standards require navigation programs, survivorship care plans, and distress screening. A multi-disciplinary survivorship clinic example integrates navigation, medical, mental health and lifestyle support for survivors. Barriers include financial sustainability and changing provider mindsets. Success comes from collaboration, tailored care, and improving survivor well-being and care coordination.
Cancer summitt 2020 buffalo aug 2011
Presentation by our Keynote Speaker, Leslie J. Kohman, MD at our Cancer Mission 2020 28th Congressional District Summit in Buffalo, NY. Dr. Kohman is the Professor of Surgery Medical Director at Upstate Cancer Center in Syracuse, NY.
Cancer and the General Internist
Cancer and the General Internist discusses how general internists can participate in cancer care. Key points include:
1. Cancer is a leading cause of death in the Philippines and costs of treatment are high, often leading to financial catastrophe for patients.
2. General internists can play roles in cancer screening, prevention through lifestyle counseling, and multidisciplinary care throughout the cancer continuum.
3. Filipinos actively search online for information about cancer signs, symptoms, and treatments. General internists are well-positioned to provide guidance and education to the public.
Breast Cancer040710
This document proposes solutions to address the growing rates of breast cancer in rural China. It aims to provide education on breast cancer causes and prevention, offer screening resources, and support patient communities. Key challenges include effective information dispersal in rural areas and developing affordable screening. Research found lack of healthcare information and links between lifestyle, diet, and cancer. The proposal is a mobile clinic with examination rooms, medical equipment, and telemedicine for education, primary care, screening, and treating simple diseases. Shipping containers are suggested for their sustainability, low-cost, and adaptability.
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docx
Running head: INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS 1
INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS 18
Ineffective Cancer treatments leading to deaths
Name
Course
Tutor
Date
Abstract
The main focus of the report will be to research on the various methods through which cancer can be treated with a keen eye on why some methods are ineffective and lead to death. A discussion on different cancer treatment will be done followed by the types of cancer that cause millions of death today. Presentation of answers to the research questions will be done in line with ineffective cancer treatment methods. Relevant literature review will be conducted and used to support the claims of ineffective cancer treatments. Lastly, recommendations on the best cancer treatment will be done.
Introduction
Cancer is an ailment caused by the unrestrained division of abnormal cells in the body. The cancer cells are malignant meaning they can spread from the origin to distant organs and tissues. The disease can be genetically hereditary hence can be crossed over from one generation to another. Some of the forms of cancer treatment include targeted therapy, hormone therapy, chemotherapy, precision medicine, surgery, immunotherapy, and stem cell transplant. Some of the common types of this disease include lung, liver, stomach, and bowel cancers.
Cancer is also called as malignancy which means abnormal cells growth. More than 100 types of cancer are found in this world today, including breast cancer (widely spread among women), skin cancer (found in the person of almost every age), lung cancer (common among smokers), colon cancer, lymphoma and prostate cancer. Each kind of cancer has varying symptoms. Cancer differs with respect to the cell it affects first. The uncontrollable division of cells harm the body and form lumps and the masses of tissues which are known as tumors. The tumor grows in size and sometimes even intervene the digestive system, circulatory system, excretory system and nervous system. In the case of leukemia, cancer inhibits the normal blood functioning which is caused due to the abnormal cell division into the blood stream. Cancer also causes the systems of the body to secrete hormones that alter the body functioning. Tumors that do not grow and remain limited to one spot are considered to slightly less harmful and benign. The sign of the more dangerous and malignant cells is:
1. The harmful cancerous cells move from one spot to another throughout the body using blood as a medium and invade the organs and the healthy tissues of the body.
2. These cells grow and divide rapidly, they make blood vessels of their own which are used by them in the process of feeding, called as angiogenesis.
Then comes a stage is known as metastasized in which the tumor spread successfully to the other parts of the body, penetrating into the healthy tissues of the body and damaging them badly. The process is known as metastasis. It cause ...
Similar to Living with Advanced Breast Cancer: Challenges and Opportunities (20)
ABC1 - M. Mayer - Keynote lecture: Living with the Advanced Breast Cancer: Ch...
ABC1 - M. Mayer - Keynote lecture: Living with the Advanced Breast Cancer: Ch...
Why screeing cancer patients for distress will increase disparities in psycho...
Why screeing cancer patients for distress will increase disparities in psycho...
Adolescents and Young Adults With Cancer Treatment and Transition to An Adult...
Adolescents and Young Adults With Cancer Treatment and Transition to An Adult...
Closing the cancer divide for women: An opportunity of lifetimes Women´s Canc...
Closing the cancer divide for women: An opportunity of lifetimes Women´s Canc...
Bridging Clinical Gaps and Disparities in Care in TNBC
Bridging Clinical Gaps and Disparities in Care in TNBC
Developing a cancer survivorship research agenda - Prof Patricia Ganz
Developing a cancer survivorship research agenda - Prof Patricia Ganz
What's New in Research for ER+ Metastatic Breast Cancer
What's New in Research for ER+ Metastatic Breast Cancer
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docx
Running head INEFFECTIVE CANCER TREATMENTS LEADING TO DEATHS1.docx
More from bkling
The Importance of Black Women Understanding the Chemicals in Their Personal C...
Certain chemicals, such as phthalates and parabens, can disrupt the body's hormones and have significant effects on health. According to data, hormone-related health issues such as uterine fibroids, infertility, early puberty and more aggressive forms of breast and endometrial cancers disproportionately affect Black women. Our guest speaker, Jasmine A. McDonald, PhD, an Assistant Professor in the Department of Epidemiology at Columbia University in New York City, discusses the scientific reasons why Black women should pay attention to specific chemicals in their personal care products, like hair care, and ways to minimize their exposure.
Let's Talk About It: Breast Cancer (Survivor’s Guilt)
The question of “Why me?” often exemplifies the experience of survivor’s guilt. Feeling survivor’s guilt is more common than you may think and can be triggered in different ways. Your positive news at a follow-up visit, regaining strength when treatment ends and manageable side effects are all events that may counter-intuitively lead to stress or even shame. Feeling the sting of hurt when others share good news and you feel the anguish of your losses, by comparison, can be hard to acknowledge and know how to manage. The loss of a fellow survivor naturally gives rise to grief which can be compounded by guilt. Let’s Talk About It.
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
Christina Spears, breast cancer genetic counselor at the Ohio State University Comprehensive Cancer Center, joined us for the MBC Support Group for Black Women to discuss the importance of genetic testing in communities of color and answer pressing questions.
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
Your mindset is the way you make sense of the world around you. This lens influences the way you think, the way you feel, and how you might behave in certain situations. Let's talk about mindset myths that can get us into trouble and ways to cultivate a mindset to support your cancer survivorship in authentic ways. Let’s Talk About It!
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Learn about body grief and ways to cope with it. We will also explore methods to heal from this challenging experience.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Making treatment decisions is stressful. The work of understanding complex medical information, crafting questions for your medical team, and trusting oneself is hard. We break down this intense time in ways that might feel more manageable and help you regain a sense of calm as you work hard to care for yourself at each turn in the road. Let’s talk about it.
Report Back from SGO: What’s the Latest in Ovarian Cancer?
Are you curious about what’s new in ovarian cancer research or unsure what the findings mean? Join Dr. Elena Pereira, a gynecologic oncologist at Lenox Hill Hospital, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Pereira will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Part I - Anticipatory Grief: Experiencing grief before the loss has happened
Anticipatory grief is the emotional experience when there is an impending loss that will occur. Often, people associate loss and grief with death, this is just one area in which grief and loss can occur. Anticipatory grief is often a slower grieving process marked by intermittent, small or large losses. In the world of cancer, anticipatory grief may show up in a variety of ways, such as before a major surgery, losing hair from chemotherapy treatment or caring for a loved one with advanced cancer.
Learn about anticipatory grief and ways to cope with it. We will also explore methods to heal from this challenging experience.
See it and Catch it! Recognizing the Thought Traps that Negatively Impact How...
A cancer diagnosis is stressful. Feelings of worry, fear, self-doubt, sadness, and loneliness are normal but can feel exhausting and consuming at times. Cultivating a habit of thought-watching and learning to recognize thought traps that might be contributing to our discomfort can help us respond and care for ourselves in helpful ways. Learn more about the connection between what we think and how we feel and what you can do about it that might impact how you feel today. Let’s talk about it.
Advocating for Better Outcomes: Ovarian Cancer and You
Many parts of your life can affect your health and your cancer risk. Things like your race, ethnicity, where you live, and your finances matter. Even so, how can you get the health care you need and lower your cancer risk? What should you and your family do if you need to speak up?
Join this special talk about knowing your risk, ovarian cancer care, and ways we can speak up to improve our health. provided by two experts from Memorial Sloan Kettering Cancer Center (MSK) and SHARE.
Embracing Life's Balancing Act - Part 1
Do you want to feel empowered and confident in preserving your independence and lowering your risk for injury? Learn how to reduce the risk of injury, how to fall safely, and maximize quality of life. Avoid common pitfalls and connect with others who share this concern!
Speakers: Ayden Jones, Falls Prevention Consultant and A Matter of Balance Master Trainer, and Janvier Hoist-Forrester, OTS.
Embracing Life's Balancing Act: Part 2 - Fall Action Plan
Do you want to feel empowered and confident in preserving your independence and lowering your risk for injury? Learn how to reduce the risk of injury, how to fall safely, and maximize quality of life. Avoid common pitfalls and connect with others who share this concern!
Speakers: Ayden Jones, Falls Prevention Consultant and A Matter of Balance Master Trainer, and Janvier Hoist-Forrester, OTS.
Let's Talk About It: Communication, Intimacy, and Sex… Oh My!
Changes to your body are normal to experience related to a cancer diagnosis. But the grief and the learning to live with a changed body take time. But what if you share your body with someone else? What if finding pleasure and connection through intimacy feels like an overwhelming or insurmountable obstacle on your road to healing? Let's talk together about our personal experiences and questions surrounding this important topic of communication and intimacy.
Let's Talk About It: To Disclose or Not to Disclose?
Sharing your cancer diagnosis with others can bring up a range of unexpected feelings and questions. Deciding who you tell, how much to share, and why are all important things to consider. The answer to these questions is personal and it varies not only between survivors but also in different settings and relationships in your life. We talk together about personal experiences and questions surrounding this important topic.
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Dr. Ebony Hoskins, gynecologic oncologist at MedStar Washington Hospital Center, provides a comprehensive update from the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer. Dr. Hoskins breaks down the research presented at the conference, discusses new developments, and addresses the most pressing questions.
Learn Tips for Managing Chemobrain or Mental Fogginess
Chemobrain, or mental fogginess, is experienced by many patients during and after cancer treatment. But what are some strategies that help?Dennis Lin, OTD, OTR/L, Occupational Therapist at City of Hope National Medical Center, will provide tips on how you can manage chemobrain and support better engagement in your daily life.
Vaccines: Will they become a form of Secondary and Primary Breast Cancer Prev...
Our guest speaker Lee Gravatt Wilke, MD, Senior Medical Director at the University of Wisconsin School of Medicine and Public Health, explains the current state of vaccine clinical trials in breast cancer followed by a review of the STEMVAC trial, design of the vaccine, and the current state of the accrual and next steps.
Let's Talk About It: Uterine Cancer (Advance Care Planning)
Although it can be a difficult topic, advance care planning is very important for anyone facing a cancer diagnosis. The goal of advance care planning is to set up a plan to make sure you get the care you want in the future. It is critical to prepare for future decisions about your medical care with your family and support system. We discuss how to start and continue those important conversations. Learn about the differences between palliative care and hospice, when to bring up your wishes with your medical team, and how to prepare your family for navigating these decisions.
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
You’ve been treated for uterine cancer. Now what? With surveillance strategies varying from doctor to doctor, it can be hard to know which advice you should follow. Dr. Jennifer Mueller, Head of the Endometrial Cancer Section, Gynecologic Oncology Service at Memorial Sloan Kettering Cancer Center, delves into surveillance guidelines, which tests to consider, and how to keep an eye out for any symptoms which could indicate recurrence.
More from bkling (20)
The Importance of Black Women Understanding the Chemicals in Their Personal C...
The Importance of Black Women Understanding the Chemicals in Their Personal C...
Let's Talk About It: Breast Cancer (Survivor’s Guilt)
Let's Talk About It: Breast Cancer (Survivor’s Guilt)
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
MBC Support Group for Black Women – Insights in Genetic Testing.pdf
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?
Part I - Anticipatory Grief: Experiencing grief before the loss has happened
Part I - Anticipatory Grief: Experiencing grief before the loss has happened
See it and Catch it! Recognizing the Thought Traps that Negatively Impact How...
See it and Catch it! Recognizing the Thought Traps that Negatively Impact How...
Advocating for Better Outcomes: Ovarian Cancer and You
Advocating for Better Outcomes: Ovarian Cancer and You
Embracing Life's Balancing Act: Part 2 - Fall Action Plan
Embracing Life's Balancing Act: Part 2 - Fall Action Plan
Let's Talk About It: Communication, Intimacy, and Sex… Oh My!
Let's Talk About It: Communication, Intimacy, and Sex… Oh My!
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Learn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental Fogginess
Vaccines: Will they become a form of Secondary and Primary Breast Cancer Prev...
Vaccines: Will they become a form of Secondary and Primary Breast Cancer Prev...
Let's Talk About It: Uterine Cancer (Advance Care Planning)
Let's Talk About It: Uterine Cancer (Advance Care Planning)
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Recently uploaded
Identifying Major Symptoms of Slip Disc.
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Role of Mukta Pishti in the Management of Hyperthyroidism
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Adhd Medication Shortage Uk - trinexpharmacy.com
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Efficacy of Avartana Sneha in Ayurveda
Avartana Sneha is a unique method of Preparation of Sneha Kalpana in Ayurveda, mainly it is indicated for the Vataja rogas.
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
All info about Diabetes and how to control it.
One health condition that is becoming more common day by day is diabetes.
According to research conducted by the National Family Health Survey of India, diabetic cases show a projection which might increase to 10.4% by 2030.
Recently uploaded (20)
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
Living with Advanced Breast Cancer: Challenges and Opportunities
- 1. Musa Mayer , MS, MFA Patient Advocate AdvancedBC.org Living with Advanced Breast Cancer: Challenges and Opportunities